Showing 1651-1660 of 21417 results for "".
- Rapid Adoption of SPRINT PNS Systems: Milestones and Clinical Impactshttps://reachmd.com/news/rapid-adoption-of-sprint-pns-systems-milestones-and-clinical-impacts/2484937/SPR Therapeutics announced that the SPR Therapeutics SPRINT PNS system has reached its 50,000th implant, re
- Innovation in Pancreatic Cancer Care: UT Health San Antonio's Breakthrough with Radiofrequency Ablationhttps://reachmd.com/news/innovation-in-pancreatic-cancer-care-ut-health-san-antonios-breakthrough-with-radiofrequency-ablation/2484938/UT Health San Antonio performed the first regional endoscopic radiofrequency ablation (RFA) for an inoperable pancreatic cancer pat
- Unlocking the Immune Code: Advances in Lichen Planus Pathogenesis and Emerging Therapieshttps://reachmd.com/news/unlocking-the-immune-code-advances-in-lichen-planus-pathogenesis-and-emerging-therapies/2484954/Once considered a relatively obscure dermatologic condition, lichen planus (LP) is gaining renewed scientific interest thanks to
- Revolutionizing Renal Replacement: Impact of the FDA's Breakthrough Device Designation for Holly Implantable Kidneyhttps://reachmd.com/news/revolutionizing-renal-replacement-impact-of-the-fdas-breakthrough-device-designation-for-holly-implantable-kidney/2484940/Nephrodite’s Holly implantable kidney
- Evaluating Nerinetide in Acute Ischemic Stroke: Insights from Latest Meta-Analysishttps://reachmd.com/news/evaluating-nerinetide-in-acute-ischemic-stroke-insights-from-latest-meta-analysis/2484951/Nerinetide, delivered intravenously as a neuroprotective adjunct during endovascular thrombectomy (EVT) when IV thrombolysis is withheld, does not improve 90‑day functional outcomes.
- Unraveling the Impact of GDF3 Signaling in Age-Related Inflammationhttps://reachmd.com/news/unraveling-the-impact-of-gdf3-signaling-in-age-related-inflammation/2484949/University of Minnesota researchers show that macrophage-derived GDF3 sustains low-grade inflammation in older adults and increases vulnerability to infection, linking aged immune cell
- Most Insurers Cover Botulinum Toxin for Axillary Hyperhidrosis: Analysishttps://reachmd.com/news/most-insurers-cover-botulinum-toxin-for-axillary-hyperhidrosis-analysis/2484933/A new cross-sectional study published in the Journal of Drugs in Dermatology finds that while botulinum toxin is broadly covered by private insurers for the treatment of primary axillary hyperhidrosis, access barriers due to
- Evaluating Targeted Therapies for Inflammatory Skin Diseases: A Focus on Baricitinib in Lichen Planushttps://reachmd.com/news/evaluating-targeted-therapies-for-inflammatory-skin-diseases-a-focus-on-baricitinib-in-lichen-planus/2484952/Mayo Clinic investigators show that baricitinib produces rapid clinical benefit in liche
- Neonatal Outcomes in Preterm Infants by Gestational Age: Insights from a Retrospective Cohort Studyhttps://reachmd.com/news/neonatal-outcomes-preterm-infants-gestational-age/2484917/A recent cohort study provides new data on short-term neonatal outcomes across late‑preterm, early‑term, and full‑term births, quantifying risks that inform timing of elective delivery.
- Regulatory Milestones for the Holly Implantable Dialysis System: A New Era in Renal Replacement Technologyhttps://reachmd.com/news/holly-implantable-dialysis-renal-replacement/2484925/The Holly implantable dialysis system has received FDA Breakthrough Device de